Company news

Bio-Techne Corp news in 2025

Bio-Techne Corp's news releases, calls and decks from 2025, newest first.

View company

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

December 22, 2025

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

December 10, 2025

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

December 8, 2025

Evolve Announces Estimated Annual Distributions for Certain Evolve Funds

December 2, 2025

Bio-Techne to Present at Upcoming Investor Conferences

November 24, 2025

Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 19, 2025

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 17, 2025

Bio-Techne Releases First Quarter Fiscal 2026 Results

November 4, 2025

Bio-Techne declares dividend

November 4, 2025

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

November 3, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

November 3, 2025

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

October 27, 2025

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

October 23, 2025

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

October 14, 2025

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

October 8, 2025

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

September 25, 2025

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

September 23, 2025

CONMED Corporation Adds Kim Kelderman to its Board of Directors

September 9, 2025

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

August 14, 2025

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

August 5, 2025

Bio-Techne Announces Exosome Diagnostics Divestiture

August 4, 2025

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering

July 31, 2025

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

July 16, 2025

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

July 14, 2025

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

July 13, 2025

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

June 23, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

June 10, 2025

Bio-Techne to Present at Investor Conferences

May 28, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

May 13, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025

May 11, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

May 7, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

May 7, 2025

Bio-Techne releases third quarter fiscal 2025 results

May 6, 2025

Bio-Techne declares dividend and new share repurchase program

May 6, 2025

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

May 6, 2025

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

April 29, 2025

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

April 23, 2025

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 22, 2025

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

April 14, 2025

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

April 1, 2025

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

March 25, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

March 23, 2025

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System

March 9, 2025

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

March 2, 2025

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

February 19, 2025

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

February 17, 2025

Bio-Techne Releases Second Quarter Fiscal 2025 Results

February 4, 2025

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

February 3, 2025

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

January 20, 2025

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

January 9, 2025

Older news releases →

Calls in 2025

Decks in 2025